Key Indices


Top Stories
Company Update | Adaro Andalan Indonesia (AADI IJ/BUY/Rp12,225/Target: Rp14,300)
- AADI's coal deliveries remained uninterrupted as of 6 Sep 26, with its South Kalimantan mines feeding Kelanis via an 80km hauling road while the disruption is concentrated in the upper Barito. Newcastle is up 37.7% ytd, and a potential El Niño supply loss of around 3.9mt per month alongside July to October seasonal demand support prices in 2H26. Kaltara's 1GW captive plant started contributing in 2Q26, and could add around US$60m to rental income. Maintain BUY. Target price: Rp14,300.
Technical Analysis
Amman Mineral Internasional | AMMN IJ
- Trading Buy Range: We have a technical Buy at Rp4,850, and take profit at Rp5,225.
Medikaloka Hermina | HEAL IJ
- Trading Buy Range: We have a technical Buy at Rp675, and take profit at Rp720.
Top Stories
Company Update | Adaro Andalan Indonesia (AADI IJ/BUY/Rp12,225/Target: Rp14,300)
- AADI's coal deliveries remained uninterrupted as of 6 Sep 26, with its South Kalimantan mines feeding Kelanis via an 80km hauling road while the disruption is concentrated in the upper Barito. Newcastle is up 37.7% ytd, and a potential El Niño supply loss of around 3.9mt per month alongside July to October seasonal demand support prices in 2H26. Kaltara's 1GW captive plant started contributing in 2Q26, and could add around US$60m to rental income. Maintain BUY. Target price: Rp14,300.
Technical Analysis
Amman Mineral Internasional | AMMN IJ
- Trading Buy Range: We have a technical Buy at Rp4,850, and take profit at Rp5,225.
Medikaloka Hermina | HEAL IJ
- Trading Buy Range: We have a technical Buy at Rp675, and take profit at Rp720.
Key Indices


IMPORTANT NOTICE - DISCLOSURES AND DISCLAIMERS
This report is provided subject to, and must be read together with, the full Disclosures / Disclaimers available at this link, which are incorporated by reference into this report. In particular, this report is intended for general circulation and informational purposes only and does not constitute personal investment advice or a recommendation to buy or sell any investment product or security. You should independently evaluate the information and, where necessary, seek advice from a qualified financial adviser regarding the suitability of any investment. Analyst certifications required under applicable regulations, including SEC Regulation AC (where relevant), are included in this report. By accessing, receiving or using this report, you acknowledge that you have read, understood and agreed to be bound by the Disclosures / Disclaimers, as may be amended, supplemented or updated from time to time.



